Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance

Title
Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance
Authors
Keywords
osteosarcoma, CRISPR-Cas9, meta-analysis, ABCB1, P-glycoprotein
Journal
Oncotarget
Volume 7, Issue 50, Pages -
Publisher
Impact Journals, LLC
Online
2016-11-07
DOI
10.18632/oncotarget.13148

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started